CNBC: Moderna's 2Q earnings beat expectations, but it writes off $500 million in expiring Covid shots.
>"Moderna took a nearly $500 million hit on write-downs for vaccine _...Read More_
CNBC: Moderna's 2Q earnings beat expectations, but it writes off $500 million in expiring Covid shots.
>"Moderna took a nearly $500 million hit on write-downs for vaccine _...Read More_
CNBC: CDC panel unanimously recommends Novavax Covid-19 vaccine for adults.
>"Novavax uses different technology than Pfizer and Moderna. U.S. _...Read More_
CNBC: CDC panel unanimously recommends Novavax Covid-19 vaccine for adults.
>"Novavax uses different technology than Pfizer and Moderna. U.S. _...Read More_